nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—TSPO—hindlimb—type 2 diabetes mellitus	0.0154	0.17	CbGeAlD
Lorazepam—UGT2B15—islet of Langerhans—type 2 diabetes mellitus	0.0126	0.14	CbGeAlD
Lorazepam—TSPO—artery—type 2 diabetes mellitus	0.00942	0.104	CbGeAlD
Lorazepam—UGT2B15—pancreas—type 2 diabetes mellitus	0.00888	0.0981	CbGeAlD
Lorazepam—UGT2B15—liver—type 2 diabetes mellitus	0.00565	0.0624	CbGeAlD
Lorazepam—TSPO—islet of Langerhans—type 2 diabetes mellitus	0.00453	0.05	CbGeAlD
Lorazepam—GABRB3—islet of Langerhans—type 2 diabetes mellitus	0.00411	0.0454	CbGeAlD
Lorazepam—TSPO—retina—type 2 diabetes mellitus	0.00387	0.0428	CbGeAlD
Lorazepam—TSPO—nephron tubule—type 2 diabetes mellitus	0.00364	0.0403	CbGeAlD
Lorazepam—TSPO—cardiovascular system—type 2 diabetes mellitus	0.00327	0.0362	CbGeAlD
Lorazepam—TSPO—kidney—type 2 diabetes mellitus	0.0032	0.0354	CbGeAlD
Lorazepam—TSPO—pancreas—type 2 diabetes mellitus	0.00318	0.0351	CbGeAlD
Lorazepam—TSPO—cortex of kidney—type 2 diabetes mellitus	0.00312	0.0345	CbGeAlD
Lorazepam—GABRB3—pancreas—type 2 diabetes mellitus	0.00289	0.0319	CbGeAlD
Lorazepam—TSPO—adipose tissue—type 2 diabetes mellitus	0.00289	0.0319	CbGeAlD
Lorazepam—TSPO—liver—type 2 diabetes mellitus	0.00202	0.0224	CbGeAlD
Lorazepam—GABRB3—liver—type 2 diabetes mellitus	0.00184	0.0203	CbGeAlD
Lorazepam—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00099	0.00135	CcSEcCtD
Lorazepam—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000987	0.00134	CcSEcCtD
Lorazepam—Convulsion—Glyburide—type 2 diabetes mellitus	0.000984	0.00134	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.00097	0.00132	CcSEcCtD
Lorazepam—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000969	0.00132	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000967	0.00132	CcSEcCtD
Lorazepam—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000966	0.00131	CcSEcCtD
Lorazepam—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000962	0.00131	CcSEcCtD
Lorazepam—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000958	0.0013	CcSEcCtD
Lorazepam—Pain—Sitagliptin—type 2 diabetes mellitus	0.000958	0.0013	CcSEcCtD
Lorazepam—Tremor—Gliclazide—type 2 diabetes mellitus	0.000955	0.0013	CcSEcCtD
Lorazepam—Alopecia—Valsartan—type 2 diabetes mellitus	0.000951	0.00129	CcSEcCtD
Lorazepam—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000951	0.00129	CcSEcCtD
Lorazepam—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000947	0.00129	CcSEcCtD
Lorazepam—Jaundice—Losartan—type 2 diabetes mellitus	0.000945	0.00129	CcSEcCtD
Lorazepam—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000942	0.00128	CcSEcCtD
Lorazepam—Alopecia—Orlistat—type 2 diabetes mellitus	0.00094	0.00128	CcSEcCtD
Lorazepam—Agitation—Gliclazide—type 2 diabetes mellitus	0.000937	0.00128	CcSEcCtD
Lorazepam—Confusional state—Glyburide—type 2 diabetes mellitus	0.000935	0.00127	CcSEcCtD
Lorazepam—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000926	0.00126	CcSEcCtD
Lorazepam—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000926	0.00126	CcSEcCtD
Lorazepam—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000923	0.00126	CcSEcCtD
Lorazepam—Rash—Repaglinide—type 2 diabetes mellitus	0.000918	0.00125	CcSEcCtD
Lorazepam—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000917	0.00125	CcSEcCtD
Lorazepam—Headache—Repaglinide—type 2 diabetes mellitus	0.000912	0.00124	CcSEcCtD
Lorazepam—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00091	0.00124	CcSEcCtD
Lorazepam—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000908	0.00124	CcSEcCtD
Lorazepam—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000905	0.00123	CcSEcCtD
Lorazepam—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000901	0.00123	CcSEcCtD
Lorazepam—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000891	0.00121	CcSEcCtD
Lorazepam—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000887	0.00121	CcSEcCtD
Lorazepam—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000886	0.00121	CcSEcCtD
Lorazepam—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000884	0.0012	CcSEcCtD
Lorazepam—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000883	0.0012	CcSEcCtD
Lorazepam—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000881	0.0012	CcSEcCtD
Lorazepam—Chills—Metformin—type 2 diabetes mellitus	0.000879	0.0012	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000875	0.00119	CcSEcCtD
Lorazepam—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000874	0.00119	CcSEcCtD
Lorazepam—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000873	0.00119	CcSEcCtD
Lorazepam—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000868	0.00118	CcSEcCtD
Lorazepam—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000867	0.00118	CcSEcCtD
Lorazepam—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000867	0.00118	CcSEcCtD
Lorazepam—Hypotension—Glyburide—type 2 diabetes mellitus	0.000866	0.00118	CcSEcCtD
Lorazepam—Nausea—Repaglinide—type 2 diabetes mellitus	0.000865	0.00118	CcSEcCtD
Lorazepam—Asthenia—Glipizide—type 2 diabetes mellitus	0.000864	0.00118	CcSEcCtD
Lorazepam—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000862	0.00117	CcSEcCtD
Lorazepam—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000859	0.00117	CcSEcCtD
Lorazepam—Erythema—Metformin—type 2 diabetes mellitus	0.000853	0.00116	CcSEcCtD
Lorazepam—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00085	0.00116	CcSEcCtD
Lorazepam—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000849	0.00116	CcSEcCtD
Lorazepam—Vertigo—Valsartan—type 2 diabetes mellitus	0.000842	0.00115	CcSEcCtD
Lorazepam—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000839	0.00114	CcSEcCtD
Lorazepam—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000836	0.00114	CcSEcCtD
Lorazepam—Vertigo—Orlistat—type 2 diabetes mellitus	0.000832	0.00113	CcSEcCtD
Lorazepam—Chills—Irbesartan—type 2 diabetes mellitus	0.00083	0.00113	CcSEcCtD
Lorazepam—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000828	0.00113	CcSEcCtD
Lorazepam—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000828	0.00113	CcSEcCtD
Lorazepam—Infection—Gliclazide—type 2 diabetes mellitus	0.000827	0.00113	CcSEcCtD
Lorazepam—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000826	0.00112	CcSEcCtD
Lorazepam—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000825	0.00112	CcSEcCtD
Lorazepam—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000817	0.00111	CcSEcCtD
Lorazepam—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000815	0.00111	CcSEcCtD
Lorazepam—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000812	0.00111	CcSEcCtD
Lorazepam—Jaundice—Ramipril—type 2 diabetes mellitus	0.00081	0.0011	CcSEcCtD
Lorazepam—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000806	0.0011	CcSEcCtD
Lorazepam—Erythema—Irbesartan—type 2 diabetes mellitus	0.000805	0.0011	CcSEcCtD
Lorazepam—Vision blurred—Metformin—type 2 diabetes mellitus	0.000804	0.00109	CcSEcCtD
Lorazepam—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000804	0.00109	CcSEcCtD
Lorazepam—Convulsion—Orlistat—type 2 diabetes mellitus	0.000802	0.00109	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.0008	0.00109	CcSEcCtD
Lorazepam—Tremor—Metformin—type 2 diabetes mellitus	0.000799	0.00109	CcSEcCtD
Lorazepam—Dizziness—Glipizide—type 2 diabetes mellitus	0.000796	0.00108	CcSEcCtD
Lorazepam—Tension—Irbesartan—type 2 diabetes mellitus	0.00079	0.00108	CcSEcCtD
Lorazepam—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000782	0.00106	CcSEcCtD
Lorazepam—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00078	0.00106	CcSEcCtD
Lorazepam—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000778	0.00106	CcSEcCtD
Lorazepam—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000778	0.00106	CcSEcCtD
Lorazepam—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000776	0.00106	CcSEcCtD
Lorazepam—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000771	0.00105	CcSEcCtD
Lorazepam—Alopecia—Losartan—type 2 diabetes mellitus	0.000769	0.00105	CcSEcCtD
Lorazepam—Vomiting—Glipizide—type 2 diabetes mellitus	0.000766	0.00104	CcSEcCtD
Lorazepam—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000764	0.00104	CcSEcCtD
Lorazepam—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000763	0.00104	CcSEcCtD
Lorazepam—Infection—Valsartan—type 2 diabetes mellitus	0.00076	0.00103	CcSEcCtD
Lorazepam—Rash—Glipizide—type 2 diabetes mellitus	0.000759	0.00103	CcSEcCtD
Lorazepam—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000759	0.00103	CcSEcCtD
Lorazepam—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000759	0.00103	CcSEcCtD
Lorazepam—Erythema—Losartan—type 2 diabetes mellitus	0.000758	0.00103	CcSEcCtD
Lorazepam—Headache—Glipizide—type 2 diabetes mellitus	0.000755	0.00103	CcSEcCtD
Lorazepam—Tremor—Irbesartan—type 2 diabetes mellitus	0.000754	0.00103	CcSEcCtD
Lorazepam—Infection—Orlistat—type 2 diabetes mellitus	0.000751	0.00102	CcSEcCtD
Lorazepam—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000749	0.00102	CcSEcCtD
Lorazepam—Tension—Losartan—type 2 diabetes mellitus	0.000744	0.00101	CcSEcCtD
Lorazepam—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000743	0.00101	CcSEcCtD
Lorazepam—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000741	0.00101	CcSEcCtD
Lorazepam—Agitation—Irbesartan—type 2 diabetes mellitus	0.00074	0.00101	CcSEcCtD
Lorazepam—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00074	0.00101	CcSEcCtD
Lorazepam—Hypertension—Metformin—type 2 diabetes mellitus	0.000737	0.001	CcSEcCtD
Lorazepam—Nervousness—Losartan—type 2 diabetes mellitus	0.000736	0.001	CcSEcCtD
Lorazepam—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000728	0.00099	CcSEcCtD
Lorazepam—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000723	0.000985	CcSEcCtD
Lorazepam—Headache—Pioglitazone—type 2 diabetes mellitus	0.000723	0.000984	CcSEcCtD
Lorazepam—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000719	0.000979	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000719	0.000978	CcSEcCtD
Lorazepam—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000718	0.000977	CcSEcCtD
Lorazepam—Nausea—Glipizide—type 2 diabetes mellitus	0.000715	0.000974	CcSEcCtD
Lorazepam—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000715	0.000973	CcSEcCtD
Lorazepam—Hypotension—Valsartan—type 2 diabetes mellitus	0.000715	0.000973	CcSEcCtD
Lorazepam—Vision blurred—Losartan—type 2 diabetes mellitus	0.000714	0.000972	CcSEcCtD
Lorazepam—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000712	0.00097	CcSEcCtD
Lorazepam—Constipation—Gliclazide—type 2 diabetes mellitus	0.000712	0.000969	CcSEcCtD
Lorazepam—Pain—Gliclazide—type 2 diabetes mellitus	0.000712	0.000969	CcSEcCtD
Lorazepam—Tremor—Losartan—type 2 diabetes mellitus	0.00071	0.000966	CcSEcCtD
Lorazepam—Rash—Glimepiride—type 2 diabetes mellitus	0.000709	0.000965	CcSEcCtD
Lorazepam—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000708	0.000964	CcSEcCtD
Lorazepam—Rash—Sitagliptin—type 2 diabetes mellitus	0.000706	0.000962	CcSEcCtD
Lorazepam—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000706	0.000961	CcSEcCtD
Lorazepam—Headache—Glimepiride—type 2 diabetes mellitus	0.000704	0.000958	CcSEcCtD
Lorazepam—Headache—Sitagliptin—type 2 diabetes mellitus	0.000702	0.000955	CcSEcCtD
Lorazepam—Agitation—Losartan—type 2 diabetes mellitus	0.000696	0.000948	CcSEcCtD
Lorazepam—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000695	0.000946	CcSEcCtD
Lorazepam—Infection—Metformin—type 2 diabetes mellitus	0.000692	0.000942	CcSEcCtD
Lorazepam—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000686	0.000934	CcSEcCtD
Lorazepam—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000683	0.00093	CcSEcCtD
Lorazepam—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000682	0.000928	CcSEcCtD
Lorazepam—Vertigo—Losartan—type 2 diabetes mellitus	0.000681	0.000927	CcSEcCtD
Lorazepam—Somnolence—Valsartan—type 2 diabetes mellitus	0.00068	0.000925	CcSEcCtD
Lorazepam—Bromazepam—CYP2E1—type 2 diabetes mellitus	0.000671	0.0446	CrCbGaD
Lorazepam—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000671	0.000913	CcSEcCtD
Lorazepam—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00067	0.000913	CcSEcCtD
Lorazepam—Nausea—Glimepiride—type 2 diabetes mellitus	0.000668	0.000909	CcSEcCtD
Lorazepam—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000667	0.000908	CcSEcCtD
Lorazepam—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000666	0.000906	CcSEcCtD
Lorazepam—Asthenia—Glyburide—type 2 diabetes mellitus	0.000665	0.000905	CcSEcCtD
Lorazepam—Amoxapine—ADRA2A—type 2 diabetes mellitus	0.000664	0.0442	CrCbGaD
Lorazepam—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00066	0.000899	CcSEcCtD
Lorazepam—Alopecia—Ramipril—type 2 diabetes mellitus	0.00066	0.000898	CcSEcCtD
Lorazepam—Fatigue—Valsartan—type 2 diabetes mellitus	0.000659	0.000897	CcSEcCtD
Lorazepam—Constipation—Valsartan—type 2 diabetes mellitus	0.000654	0.00089	CcSEcCtD
Lorazepam—Infection—Irbesartan—type 2 diabetes mellitus	0.000653	0.000889	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000652	0.000888	CcSEcCtD
Lorazepam—Fatigue—Orlistat—type 2 diabetes mellitus	0.000651	0.000887	CcSEcCtD
Lorazepam—Hypotension—Metformin—type 2 diabetes mellitus	0.000651	0.000886	CcSEcCtD
Lorazepam—Erythema—Ramipril—type 2 diabetes mellitus	0.00065	0.000884	CcSEcCtD
Lorazepam—Pain—Orlistat—type 2 diabetes mellitus	0.000646	0.00088	CcSEcCtD
Lorazepam—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000645	0.000878	CcSEcCtD
Lorazepam—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000643	0.000876	CcSEcCtD
Lorazepam—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000641	0.000873	CcSEcCtD
Lorazepam—Rash—Bromocriptine—type 2 diabetes mellitus	0.000639	0.00087	CcSEcCtD
Lorazepam—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000639	0.000869	CcSEcCtD
Lorazepam—Bromazepam—CYP1A2—type 2 diabetes mellitus	0.000638	0.0425	CrCbGaD
Lorazepam—Tension—Ramipril—type 2 diabetes mellitus	0.000638	0.000868	CcSEcCtD
Lorazepam—Headache—Bromocriptine—type 2 diabetes mellitus	0.000635	0.000865	CcSEcCtD
Lorazepam—Nervousness—Ramipril—type 2 diabetes mellitus	0.000631	0.000859	CcSEcCtD
Lorazepam—Dry mouth—Losartan—type 2 diabetes mellitus	0.000631	0.000859	CcSEcCtD
Lorazepam—Clonazepam—CYP2E1—type 2 diabetes mellitus	0.000629	0.0419	CrCbGaD
Lorazepam—Confusional state—Losartan—type 2 diabetes mellitus	0.000624	0.000849	CcSEcCtD
Lorazepam—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000623	0.000848	CcSEcCtD
Lorazepam—Somnolence—Metformin—type 2 diabetes mellitus	0.000619	0.000843	CcSEcCtD
Lorazepam—Infection—Losartan—type 2 diabetes mellitus	0.000614	0.000836	CcSEcCtD
Lorazepam—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000614	0.000836	CcSEcCtD
Lorazepam—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000613	0.000835	CcSEcCtD
Lorazepam—Amoxapine—HTR2C—type 2 diabetes mellitus	0.000611	0.0407	CrCbGaD
Lorazepam—Tremor—Ramipril—type 2 diabetes mellitus	0.000609	0.000829	CcSEcCtD
Lorazepam—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000606	0.000824	CcSEcCtD
Lorazepam—Tachycardia—Losartan—type 2 diabetes mellitus	0.000604	0.000822	CcSEcCtD
Lorazepam—Diclofenac—CYP2E1—type 2 diabetes mellitus	0.000603	0.0401	CrCbGaD
Lorazepam—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000602	0.00082	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000601	0.000818	CcSEcCtD
Lorazepam—Fatigue—Metformin—type 2 diabetes mellitus	0.0006	0.000817	CcSEcCtD
Lorazepam—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000597	0.000813	CcSEcCtD
Lorazepam—Agitation—Ramipril—type 2 diabetes mellitus	0.000597	0.000813	CcSEcCtD
Lorazepam—Constipation—Metformin—type 2 diabetes mellitus	0.000596	0.000811	CcSEcCtD
Lorazepam—Vomiting—Glyburide—type 2 diabetes mellitus	0.000589	0.000802	CcSEcCtD
Lorazepam—Rash—Glyburide—type 2 diabetes mellitus	0.000584	0.000796	CcSEcCtD
Lorazepam—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000584	0.000795	CcSEcCtD
Lorazepam—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000584	0.000795	CcSEcCtD
Lorazepam—Vertigo—Ramipril—type 2 diabetes mellitus	0.000584	0.000795	CcSEcCtD
Lorazepam—Headache—Glyburide—type 2 diabetes mellitus	0.000581	0.00079	CcSEcCtD
Lorazepam—Hypotension—Losartan—type 2 diabetes mellitus	0.000578	0.000787	CcSEcCtD
Lorazepam—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000574	0.000781	CcSEcCtD
Lorazepam—Diclofenac—CYP1A2—type 2 diabetes mellitus	0.000574	0.0382	CrCbGaD
Lorazepam—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000567	0.000772	CcSEcCtD
Lorazepam—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000567	0.000771	CcSEcCtD
Lorazepam—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000563	0.000767	CcSEcCtD
Lorazepam—Convulsion—Ramipril—type 2 diabetes mellitus	0.000563	0.000766	CcSEcCtD
Lorazepam—Pain—Irbesartan—type 2 diabetes mellitus	0.000562	0.000765	CcSEcCtD
Lorazepam—Constipation—Irbesartan—type 2 diabetes mellitus	0.000562	0.000765	CcSEcCtD
Lorazepam—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000557	0.000758	CcSEcCtD
Lorazepam—Nausea—Glyburide—type 2 diabetes mellitus	0.000551	0.000749	CcSEcCtD
Lorazepam—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00055	0.000749	CcSEcCtD
Lorazepam—Somnolence—Losartan—type 2 diabetes mellitus	0.00055	0.000748	CcSEcCtD
Lorazepam—Asthenia—Valsartan—type 2 diabetes mellitus	0.000549	0.000747	CcSEcCtD
Lorazepam—Chlorprothixene—HTR2C—type 2 diabetes mellitus	0.000547	0.0364	CrCbGaD
Lorazepam—Asthenia—Orlistat—type 2 diabetes mellitus	0.000542	0.000738	CcSEcCtD
Lorazepam—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000542	0.000737	CcSEcCtD
Lorazepam—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000541	0.000736	CcSEcCtD
Lorazepam—Confusional state—Ramipril—type 2 diabetes mellitus	0.000535	0.000728	CcSEcCtD
Lorazepam—Fatigue—Losartan—type 2 diabetes mellitus	0.000533	0.000726	CcSEcCtD
Lorazepam—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000529	0.00072	CcSEcCtD
Lorazepam—Pain—Losartan—type 2 diabetes mellitus	0.000529	0.00072	CcSEcCtD
Lorazepam—Constipation—Losartan—type 2 diabetes mellitus	0.000529	0.00072	CcSEcCtD
Lorazepam—Rash—Gliclazide—type 2 diabetes mellitus	0.000525	0.000714	CcSEcCtD
Lorazepam—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000524	0.000714	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—CDO1—type 2 diabetes mellitus	0.000523	0.00327	CbGpPWpGaD
Lorazepam—Headache—Gliclazide—type 2 diabetes mellitus	0.000521	0.00071	CcSEcCtD
Lorazepam—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000519	0.000707	CcSEcCtD
Lorazepam—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000518	0.000704	CcSEcCtD
Lorazepam—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00051	0.000694	CcSEcCtD
Lorazepam—Dizziness—Valsartan—type 2 diabetes mellitus	0.000506	0.000688	CcSEcCtD
Lorazepam—GABRB3—Orphan transporters—APOB—type 2 diabetes mellitus	0.000502	0.00314	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.0005	0.00313	CbGpPWpGaD
Lorazepam—Dizziness—Orlistat—type 2 diabetes mellitus	0.0005	0.00068	CcSEcCtD
Lorazepam—Asthenia—Metformin—type 2 diabetes mellitus	0.0005	0.00068	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—AK1—type 2 diabetes mellitus	0.000499	0.00312	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000499	0.00312	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GAD2—type 2 diabetes mellitus	0.000496	0.00311	CbGpPWpGaD
Lorazepam—Hypotension—Ramipril—type 2 diabetes mellitus	0.000496	0.000674	CcSEcCtD
Lorazepam—Nausea—Gliclazide—type 2 diabetes mellitus	0.000494	0.000673	CcSEcCtD
Lorazepam—GABRG2—Orphan transporters—APOB—type 2 diabetes mellitus	0.000493	0.00308	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—GAD2—type 2 diabetes mellitus	0.000487	0.00305	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000487	0.00305	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000487	0.00305	CbGpPWpGaD
Lorazepam—Vomiting—Valsartan—type 2 diabetes mellitus	0.000486	0.000662	CcSEcCtD
Lorazepam—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000484	0.000659	CcSEcCtD
Lorazepam—Rash—Valsartan—type 2 diabetes mellitus	0.000482	0.000656	CcSEcCtD
Lorazepam—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000482	0.000656	CcSEcCtD
Lorazepam—Vomiting—Orlistat—type 2 diabetes mellitus	0.00048	0.000654	CcSEcCtD
Lorazepam—Headache—Valsartan—type 2 diabetes mellitus	0.000479	0.000652	CcSEcCtD
Lorazepam—Rash—Orlistat—type 2 diabetes mellitus	0.000476	0.000648	CcSEcCtD
Lorazepam—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000476	0.000648	CcSEcCtD
Lorazepam—Headache—Orlistat—type 2 diabetes mellitus	0.000473	0.000644	CcSEcCtD
Lorazepam—GABRA1—Ion channel transport—ATP2A2—type 2 diabetes mellitus	0.000473	0.00296	CbGpPWpGaD
Lorazepam—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000472	0.000642	CcSEcCtD
Lorazepam—Somnolence—Ramipril—type 2 diabetes mellitus	0.000471	0.000642	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000461	0.00288	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—MAT1A—type 2 diabetes mellitus	0.000461	0.00288	CbGpPWpGaD
Lorazepam—Dizziness—Metformin—type 2 diabetes mellitus	0.000461	0.000627	CcSEcCtD
Lorazepam—GABRA1—Ion channel transport—TRPC6—type 2 diabetes mellitus	0.000459	0.00287	CbGpPWpGaD
Lorazepam—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000458	0.000623	CcSEcCtD
Lorazepam—Fatigue—Ramipril—type 2 diabetes mellitus	0.000457	0.000622	CcSEcCtD
Lorazepam—Nitrazepam—CYP2E1—type 2 diabetes mellitus	0.000456	0.0303	CrCbGaD
Lorazepam—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000456	0.00062	CcSEcCtD
Lorazepam—Nausea—Valsartan—type 2 diabetes mellitus	0.000454	0.000618	CcSEcCtD
Lorazepam—Constipation—Ramipril—type 2 diabetes mellitus	0.000453	0.000617	CcSEcCtD
Lorazepam—GABRB3—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000449	0.00281	CbGpPWpGaD
Lorazepam—Nausea—Orlistat—type 2 diabetes mellitus	0.000449	0.000611	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000445	0.00278	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ND1—type 2 diabetes mellitus	0.000445	0.00278	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ENPP1—type 2 diabetes mellitus	0.000445	0.00278	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—G6PC—type 2 diabetes mellitus	0.000445	0.00278	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HBA2—type 2 diabetes mellitus	0.000445	0.00278	CbGpPWpGaD
Lorazepam—Asthenia—Losartan—type 2 diabetes mellitus	0.000444	0.000604	CcSEcCtD
Lorazepam—Vomiting—Metformin—type 2 diabetes mellitus	0.000443	0.000603	CcSEcCtD
Lorazepam—GABRG2—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000441	0.00276	CbGpPWpGaD
Lorazepam—Rash—Metformin—type 2 diabetes mellitus	0.000439	0.000598	CcSEcCtD
Lorazepam—Dermatitis—Metformin—type 2 diabetes mellitus	0.000439	0.000597	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000437	0.00274	CbGpPWpGaD
Lorazepam—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000437	0.000595	CcSEcCtD
Lorazepam—Headache—Metformin—type 2 diabetes mellitus	0.000436	0.000594	CcSEcCtD
Lorazepam—Clozapine—ADRA2A—type 2 diabetes mellitus	0.000435	0.029	CrCbGaD
Lorazepam—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000435	0.000592	CcSEcCtD
Lorazepam—GABRA1—Orphan transporters—APOB—type 2 diabetes mellitus	0.000431	0.0027	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GCGR—type 2 diabetes mellitus	0.000431	0.0027	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GAD2—type 2 diabetes mellitus	0.000426	0.00267	CbGpPWpGaD
Lorazepam—GABRB3—Orphan transporters—PPARA—type 2 diabetes mellitus	0.000423	0.00265	CbGpPWpGaD
Lorazepam—Bromazepam—CYP3A4—type 2 diabetes mellitus	0.000422	0.0281	CrCbGaD
Lorazepam—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000418	0.000569	CcSEcCtD
Lorazepam—GABRB3—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000417	0.00261	CbGpPWpGaD
Lorazepam—GABRG2—Orphan transporters—PPARA—type 2 diabetes mellitus	0.000416	0.0026	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000415	0.0026	CbGpPWpGaD
Lorazepam—Rash—Irbesartan—type 2 diabetes mellitus	0.000414	0.000564	CcSEcCtD
Lorazepam—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000414	0.000563	CcSEcCtD
Lorazepam—Nausea—Metformin—type 2 diabetes mellitus	0.000414	0.000563	CcSEcCtD
Lorazepam—Headache—Irbesartan—type 2 diabetes mellitus	0.000412	0.00056	CcSEcCtD
Lorazepam—Chlordiazepoxide—CYP3A4—type 2 diabetes mellitus	0.00041	0.0273	CrCbGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.00041	0.00257	CbGpPWpGaD
Lorazepam—Dizziness—Losartan—type 2 diabetes mellitus	0.000409	0.000557	CcSEcCtD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000407	0.00255	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—OXCT1—type 2 diabetes mellitus	0.000407	0.00255	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYTB—type 2 diabetes mellitus	0.000407	0.00255	CbGpPWpGaD
Lorazepam—Flurazepam—CYP2E1—type 2 diabetes mellitus	0.000405	0.027	CrCbGaD
Lorazepam—Clozapine—HTR2C—type 2 diabetes mellitus	0.000401	0.0267	CrCbGaD
Lorazepam—UGT2B15—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000396	0.00248	CbGpPWpGaD
Lorazepam—Clonazepam—CYP3A4—type 2 diabetes mellitus	0.000396	0.0264	CrCbGaD
Lorazepam—Vomiting—Losartan—type 2 diabetes mellitus	0.000393	0.000535	CcSEcCtD
Lorazepam—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000391	0.000532	CcSEcCtD
Lorazepam—Nausea—Irbesartan—type 2 diabetes mellitus	0.00039	0.000531	CcSEcCtD
Lorazepam—Rash—Losartan—type 2 diabetes mellitus	0.00039	0.000531	CcSEcCtD
Lorazepam—Dermatitis—Losartan—type 2 diabetes mellitus	0.00039	0.00053	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000388	0.00243	CbGpPWpGaD
Lorazepam—Headache—Losartan—type 2 diabetes mellitus	0.000387	0.000527	CcSEcCtD
Lorazepam—GABRA1—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000385	0.00241	CbGpPWpGaD
Lorazepam—Clorazepate—CYP3A4—type 2 diabetes mellitus	0.000384	0.0255	CrCbGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000381	0.00238	CbGpPWpGaD
Lorazepam—Asthenia—Ramipril—type 2 diabetes mellitus	0.00038	0.000518	CcSEcCtD
Lorazepam—Diclofenac—CYP3A4—type 2 diabetes mellitus	0.00038	0.0253	CrCbGaD
Lorazepam—UGT2B15—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000378	0.00237	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ACACA—type 2 diabetes mellitus	0.000378	0.00237	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—STAR—type 2 diabetes mellitus	0.000378	0.00237	CbGpPWpGaD
Lorazepam—Midazolam—CYP2E1—type 2 diabetes mellitus	0.000376	0.025	CrCbGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000374	0.00234	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000374	0.00234	CbGpPWpGaD
Lorazepam—Diclofenac—PTGS2—type 2 diabetes mellitus	0.000372	0.0247	CrCbGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.00037	0.00231	CbGpPWpGaD
Lorazepam—Clotiazepam—CYP3A4—type 2 diabetes mellitus	0.000368	0.0245	CrCbGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000368	0.0023	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000368	0.0023	CbGpPWpGaD
Lorazepam—Nausea—Losartan—type 2 diabetes mellitus	0.000367	0.0005	CcSEcCtD
Lorazepam—GABRA1—Orphan transporters—PPARA—type 2 diabetes mellitus	0.000363	0.00227	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000363	0.00227	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ABCC8—type 2 diabetes mellitus	0.000363	0.00227	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CBS—type 2 diabetes mellitus	0.000363	0.00227	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000358	0.00224	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000356	0.00223	CbGpPWpGaD
Lorazepam—Dizziness—Ramipril—type 2 diabetes mellitus	0.000351	0.000477	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000349	0.00219	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000349	0.00218	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—COX2—type 2 diabetes mellitus	0.000349	0.00218	CbGpPWpGaD
Lorazepam—Alprazolam—CYP3A4—type 2 diabetes mellitus	0.000347	0.0231	CrCbGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000347	0.00217	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—PPP2CA—type 2 diabetes mellitus	0.000347	0.00217	CbGpPWpGaD
Lorazepam—Clonazepam—ALB—type 2 diabetes mellitus	0.000346	0.023	CrCbGaD
Lorazepam—UGT2B15—Metabolism—NCOA6—type 2 diabetes mellitus	0.000343	0.00215	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000343	0.00214	CbGpPWpGaD
Lorazepam—Vomiting—Ramipril—type 2 diabetes mellitus	0.000337	0.000459	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—UCP3—type 2 diabetes mellitus	0.000337	0.00211	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—UCP2—type 2 diabetes mellitus	0.000337	0.00211	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000337	0.00211	CbGpPWpGaD
Lorazepam—Quazepam—CYP3A4—type 2 diabetes mellitus	0.000337	0.0224	CrCbGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000336	0.00211	CbGpPWpGaD
Lorazepam—Rash—Ramipril—type 2 diabetes mellitus	0.000334	0.000455	CcSEcCtD
Lorazepam—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000334	0.000455	CcSEcCtD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000333	0.00208	CbGpPWpGaD
Lorazepam—Headache—Ramipril—type 2 diabetes mellitus	0.000332	0.000452	CcSEcCtD
Lorazepam—Diclofenac—ALB—type 2 diabetes mellitus	0.000331	0.022	CrCbGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000327	0.00204	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000327	0.00204	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000322	0.00202	CbGpPWpGaD
Lorazepam—Diazepam—CYP2E1—type 2 diabetes mellitus	0.000322	0.0214	CrCbGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000321	0.00201	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000321	0.00201	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—SNAP25—type 2 diabetes mellitus	0.00032	0.002	CbGpPWpGaD
Lorazepam—Clozapine—CYP2E1—type 2 diabetes mellitus	0.000318	0.0212	CrCbGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000318	0.00199	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000317	0.00199	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PCK1—type 2 diabetes mellitus	0.000317	0.00198	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—IRS2—type 2 diabetes mellitus	0.000316	0.00198	CbGpPWpGaD
Lorazepam—Nausea—Ramipril—type 2 diabetes mellitus	0.000315	0.000429	CcSEcCtD
Lorazepam—GABRG2—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000314	0.00197	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000312	0.00195	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000312	0.00195	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000306	0.00192	CbGpPWpGaD
Lorazepam—Diazepam—CYP1A2—type 2 diabetes mellitus	0.000306	0.0204	CrCbGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000305	0.00191	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000305	0.00191	CbGpPWpGaD
Lorazepam—Clozapine—CYP1A2—type 2 diabetes mellitus	0.000302	0.0201	CrCbGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.0003	0.00188	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.0003	0.00188	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000299	0.00187	CbGpPWpGaD
Lorazepam—Estazolam—CYP3A4—type 2 diabetes mellitus	0.000297	0.0198	CrCbGaD
Lorazepam—UGT2B15—Metabolism—HK1—type 2 diabetes mellitus	0.000297	0.00186	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000294	0.00184	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000294	0.00184	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000294	0.00184	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000293	0.00184	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000289	0.00181	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000289	0.00181	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000289	0.00181	CbGpPWpGaD
Lorazepam—Nitrazepam—CYP3A4—type 2 diabetes mellitus	0.000287	0.0191	CrCbGaD
Lorazepam—UGT2B15—Metabolism—LPA—type 2 diabetes mellitus	0.000287	0.00179	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GCKR—type 2 diabetes mellitus	0.000287	0.00179	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000287	0.00179	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000287	0.00179	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000283	0.00177	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.00028	0.00175	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000278	0.00174	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—IRS1—type 2 diabetes mellitus	0.000276	0.00173	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ALDOB—type 2 diabetes mellitus	0.000275	0.00172	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000275	0.00172	CbGpPWpGaD
Lorazepam—Prazepam—CYP3A4—type 2 diabetes mellitus	0.000274	0.0182	CrCbGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000273	0.00171	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000273	0.00171	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000268	0.00168	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000267	0.00167	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000262	0.00164	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000262	0.00164	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000262	0.00164	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000256	0.0016	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GLP1R—type 2 diabetes mellitus	0.000255	0.0016	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000255	0.0016	CbGpPWpGaD
Lorazepam—Flurazepam—CYP3A4—type 2 diabetes mellitus	0.000255	0.017	CrCbGaD
Lorazepam—Triazolam—CYP3A4—type 2 diabetes mellitus	0.000255	0.017	CrCbGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000252	0.00158	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000252	0.00158	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.00025	0.00156	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000248	0.00155	CbGpPWpGaD
Lorazepam—Oxazepam—CYP3A4—type 2 diabetes mellitus	0.000247	0.0164	CrCbGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000245	0.00154	CbGpPWpGaD
Lorazepam—Temazepam—CYP3A4—type 2 diabetes mellitus	0.000244	0.0162	CrCbGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000241	0.00151	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GNB3—type 2 diabetes mellitus	0.000239	0.0015	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000239	0.0015	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000239	0.00149	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000238	0.00149	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000237	0.00148	CbGpPWpGaD
Lorazepam—Midazolam—CYP3A4—type 2 diabetes mellitus	0.000237	0.0157	CrCbGaD
Lorazepam—GABRG2—Neuronal System—GNB3—type 2 diabetes mellitus	0.000235	0.00147	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000235	0.00147	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CPT1A—type 2 diabetes mellitus	0.000234	0.00146	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—MTR—type 2 diabetes mellitus	0.000234	0.00146	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—PIK3R1—type 2 diabetes mellitus	0.000232	0.00145	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000231	0.00145	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NAMPT—type 2 diabetes mellitus	0.000229	0.00143	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000229	0.00143	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HBA1—type 2 diabetes mellitus	0.000228	0.00143	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LIPC—type 2 diabetes mellitus	0.000228	0.00143	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GCK—type 2 diabetes mellitus	0.000228	0.00143	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000227	0.00142	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000226	0.00142	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000224	0.00141	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000222	0.00139	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.00022	0.00138	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CETP—type 2 diabetes mellitus	0.00022	0.00137	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—RELA—type 2 diabetes mellitus	0.000218	0.00137	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000214	0.00134	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000213	0.00133	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000209	0.00131	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000207	0.0013	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GNB3—type 2 diabetes mellitus	0.000205	0.00128	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000205	0.00128	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PSMD6—type 2 diabetes mellitus	0.000204	0.00128	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SNAP25—type 2 diabetes mellitus	0.000204	0.00128	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SREBF1—type 2 diabetes mellitus	0.000204	0.00128	CbGpPWpGaD
Lorazepam—Diazepam—CYP3A4—type 2 diabetes mellitus	0.000203	0.0135	CrCbGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000201	0.00126	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CTGF—type 2 diabetes mellitus	0.0002	0.00125	CbGpPWpGaD
Lorazepam—Clozapine—CYP3A4—type 2 diabetes mellitus	0.0002	0.0133	CrCbGaD
Lorazepam—UGT2B15—Metabolism—HMGCR—type 2 diabetes mellitus	0.000199	0.00124	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000199	0.00124	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000197	0.00123	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—CASP3—type 2 diabetes mellitus	0.000197	0.00123	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000194	0.00122	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000193	0.00121	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000192	0.0012	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000192	0.0012	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000188	0.00118	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000188	0.00118	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000187	0.00117	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000187	0.00117	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000186	0.00116	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000185	0.00116	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000185	0.00116	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000185	0.00116	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—NFKB1—type 2 diabetes mellitus	0.000184	0.00115	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000184	0.00115	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CALM1—type 2 diabetes mellitus	0.000183	0.00115	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000183	0.00114	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000183	0.00114	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000182	0.00114	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP3A4—type 2 diabetes mellitus	0.00018	0.00113	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CALM1—type 2 diabetes mellitus	0.00018	0.00112	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000177	0.00111	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GCG—type 2 diabetes mellitus	0.000177	0.00111	CbGpPWpGaD
Lorazepam—Diazepam—ALB—type 2 diabetes mellitus	0.000177	0.0118	CrCbGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000172	0.00108	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000172	0.00108	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—SRC—type 2 diabetes mellitus	0.000172	0.00107	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000169	0.00106	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000165	0.00103	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000165	0.00103	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000163	0.00102	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000161	0.00101	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.00016	0.001	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.00016	0.000999	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000159	0.000994	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000159	0.000992	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CALM1—type 2 diabetes mellitus	0.000157	0.000983	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000156	0.000973	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000153	0.000956	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GNB3—type 2 diabetes mellitus	0.000153	0.000955	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000153	0.000955	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HMOX1—type 2 diabetes mellitus	0.000152	0.000951	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CAT—type 2 diabetes mellitus	0.00015	0.000938	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000149	0.000933	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000148	0.000928	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000148	0.000924	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000146	0.000916	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOB—type 2 diabetes mellitus	0.000146	0.000911	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTM1—type 2 diabetes mellitus	0.000142	0.000886	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.00014	0.000876	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LPL—type 2 diabetes mellitus	0.000139	0.00087	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ADCY5—type 2 diabetes mellitus	0.000136	0.000851	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GPX1—type 2 diabetes mellitus	0.000136	0.000848	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000135	0.000842	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000133	0.000835	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CD36—type 2 diabetes mellitus	0.000132	0.000826	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPP2CA—type 2 diabetes mellitus	0.00013	0.000816	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000128	0.000804	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000128	0.000801	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000128	0.000801	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000127	0.000793	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000126	0.00079	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000126	0.000786	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—MTHFR—type 2 diabetes mellitus	0.000125	0.000783	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000124	0.000779	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARA—type 2 diabetes mellitus	0.000123	0.000768	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000123	0.000767	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.00012	0.000753	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AGT—type 2 diabetes mellitus	0.000119	0.000744	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CALM1—type 2 diabetes mellitus	0.000117	0.000731	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOE—type 2 diabetes mellitus	0.000116	0.000729	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000115	0.000722	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOA1—type 2 diabetes mellitus	0.000115	0.000721	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000115	0.000717	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000112	0.000704	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.00011	0.00069	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.00011	0.000687	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000109	0.000681	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—AKT1—type 2 diabetes mellitus	0.000107	0.000667	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000105	0.000658	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000103	0.000647	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000101	0.000635	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARG—type 2 diabetes mellitus	0.000101	0.000635	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—INS—type 2 diabetes mellitus	9.95e-05	0.000623	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	9.83e-05	0.000615	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.69e-05	0.000607	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.52e-05	0.000596	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	9.3e-05	0.000582	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ALB—type 2 diabetes mellitus	9.12e-05	0.000571	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.87e-05	0.000555	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3R1—type 2 diabetes mellitus	8.73e-05	0.000546	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NOS3—type 2 diabetes mellitus	8.73e-05	0.000546	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.32e-05	0.000521	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PTGS2—type 2 diabetes mellitus	7.98e-05	0.000499	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.68e-05	0.000481	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.54e-05	0.000472	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.59e-05	0.000413	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AKT1—type 2 diabetes mellitus	4.01e-05	0.000251	CbGpPWpGaD
